CC FINANCIAL STATEMENTS

Chemours Co — balance sheet, income statement and cash flow trends

CCChemours Co

🇺🇸 USA · NYSE · Basic Materials · Specialty Chemicals

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue5.8 B $+0.1%

Gross Profit881 M $-20.1%

Operating Income-19 M $-104.7%

EBITDA132 M $-79.2%

Net Income-411 M $-2,057.1%

Peer Comparison· Specialty Chemicals

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CC	0.1%	15.1%	2.3%	-7.1%
SASA	4.0%	7.7%	15.6%	-36.0%
DNL	-16.6%	27.9%	17.8%	4.5%
IMCD	1.2%	17.7%	10.9%	4.5%
ORI	1.8%	19.2%	17.3%	3.1%
BNR	-9.5%	18.6%	7.9%	1.5%
Industry median	1.2%	26.7%	14.7%	3.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
CC	0.1%	15.1%	2.3%	-7.1%
HWKN	11.2%	22.6%	16.2%	7.5%
KWR	6.3%	34.4%	8.8%	0.2%
ASH	-7.2%	25.2%	-16.3%	-39.0%
NGVT	-10.3%	39.3%	1.4%	-10.6%
FUL	-0.6%	32.5%	14.6%	5.3%
Industry median	1.2%	26.7%	14.7%	3.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity215 M $3%
Current Liabilities1.6 B $22%
Long-term Liabilities5.4 B $75%

Key Figures

YoY change

Total Assets7.3 B $-1.7%

Total Liabilities7.1 B $+3.5%

Total Equity215 M $-62.9%

Cash & ST Investments563 M $+21.3%

Total Debt4.4 B $+0.2%

Net Debt3.8 B $-2.3%

Peer Comparison· Specialty Chemicals

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CC	1.82	2,042.3%	29.00	3.0%
SASA	0.63	83.7%	14.70	48.5%
DNL	1.27	39.7%	2.15	57.8%
IMCD	1.73	83.4%	2.81	44.0%
ORI	1.31	86.9%	1.77	38.5%
BNR	1.74	75.4%	2.31	40.0%
Industry median	1.87	63.0%	2.15	46.9%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
CC	1.82	2,042.3%	29.00	3.0%
HWKN	2.21	49.0%	1.47	53.3%
KWR	2.45	65.2%	4.31	49.1%
ASH	3.06	79.2%	-3.86	41.5%
NGVT	1.42	3,199.7%	67.21	2.4%
FUL	1.80	99.5%	3.83	39.1%
Industry median	1.87	63.0%	2.15	46.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow332 M $—

Capital Expenditures178 M $-48.0%

Free Cash Flow154 M $—

Dividends Paid-54 M $-136.5%

Peer Comparison· Specialty Chemicals

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CC	5.7%	2.6%	3.1%	-80.8%
SASA	13.5%	3.8%	10.3%	-37.5%
DNL	9.3%	-0.2%	9.5%	205.3%
IMCD	6.7%	6.5%	0.3%	148.1%
ORI	11.6%	6.2%	5.4%	372.9%
BNR	6.4%	4.4%	2.0%	415.2%
Industry median	9.6%	5.8%	5.0%	111.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
CC	5.7%	2.6%	3.1%	-80.8%
HWKN	13.3%	7.9%	5.4%	177.0%
KWR	7.4%	7.4%	1.3%	3,364.4%
ASH	22.4%	18.5%	3.9%	-57.4%
NGVT	25.1%	20.3%	4.8%	-237.7%
FUL	9.2%	4.0%	5.2%	173.8%
Industry median	9.6%	5.8%	5.0%	111.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.